Michael was Board Member at Zalicus, and Chief Medical Officer at Onyx Pharmaceuticals. Michael Kauffman joined Verastem Oncology in 2023.
Michael Kauffman is currently
Create your alert
to follow the career of Michael Kauffman.
In 1992, Michael Kauffman completed a PhD in Molecular Biology and Biochemistry at Johns Hopkins School of Medicine.
They have also studied at Johns Hopkins School of Medicine :
Find more alumni from Johns Hopkins School of Medicine
Do you need to know more about Michael Kauffman? More results.
Report an error
Update the org chart details of Michael Kauffman.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.